Devyser Diagnostics AB (publ)

kr 64.80As of Sun 8 Nov 2026, 12:00 UTC
STO:DVYSRHealthcare
Country Sweden
PE (Fwd) •••
TSR 5Y CAGR (6.24%)
Div yield —
ROE 6.96%
Medical Devices
Beta (5Y) 0.80
PE TTM 43.10
TSR TTM (50.08%)
Mkt cap kr 1.094B
ROIC 7.02%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 73
12.49%
(47.35%)
Hold 9|6|7|12|7
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
1.10
1.18
1.31
1.45
19.82%
28.56%
29.75%
40.69%
Revenuekr M
124.8
125.5
131.2
127.7
12.81%
7.96%
7.76%
(0.41%)
Peers (US$110.6M)
Cap (US$)
PE
147.1M
—
81.93M
17.01x
110.5M
—
Capital
TTM
5Y
10Y
Leveragex
1.145
0.308
0.287
EBIT/Intx
1.339
0.690
0.593
Own earn%
10.12
122.14
112.81
Sh yield%
38.19
27.50
21.13
Owners
Insiders/Inst%
4.69
29.70
Short interest%
2.67
SBC / revenue%
1.43
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
7–14
$1 testx
—
Incr. ROIC%
3